Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

BENGALURU: Karnataka is emerging as a key player in the dermatology and cosmetic medical treatment sectors, with significant investment opportunities coming up, particularly in the upcoming KWIN City project, said Industries and Infrastructure Development Minister MB Patil on Friday.

At the inauguration of the Bharat Summit of Laser Medicine and Surgery 2025, Patil highlighted the state’s advancements in medical device manufacturing and pharmaceutical startups and noted that Karnataka currently manufactures 350 critical medical instruments and is home to hundreds of startups in the medical and pharmaceutical sectors, which are actively driving healthcare innovation.

Patil emphasised that Karnataka is at the forefront of producing medical IT solutions, PCR machines, stents for heart treatments, insulin pens, and other key medical devices.

He added that the medical devices, digital health, and diagnostics sectors are undergoing rapid transformation, with state-based companies leading technological advancements in these areas.

During the four-day international conference, Patil stressed that affordable healthcare and speedy treatment are essential for building credibility in the industry. The conference, which will conclude on Sunday, March 23, brought together over 1,200 delegates from around the world for discussions.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert